A 12-year retrospective analysis was done to identify and evaluate in detail cases of invasive pulmonary aspergillosis (IPA) caused by Aspergillus terreus. We identified 13 A. terreus infections among 133 total cases of confirmed invasive aspergillosis; 11 were IPA and 2 were primary peritoneal infections. Of the 11 patients with IPA, 7 developed neutropenia during hospitalization, and the remaining four were receiving immunosuppressive agents. Ten patients with IPA died; one liver transplantation patient without neutropenia survived after treatment with amphotericin B, itraconazole, and a pulmonary lobectomy. Six patients developed disseminated disease, with the heart the most common extrapulmonary site identified (four patients). These cases demonstrate that IPA caused by A. terreus rapidly progresses in immunocompromised patients receiving amphotericin B and illustrate the need for sensitive diagnostic tests and more effective antifungal agents.
Invasive aspergillosis is the most common invasive mold
Our observations raised the concern that A. terreus is associated with higher morbidity and mortality than are other species, infection occurring in immunocompromised patients [1 -6] . Primary infection usually involves the respiratory tract followwhich led us to conduct a retrospective 12-year analysis to determine the frequency of IPA caused by A. terreus in comparing environmental exposure to Aspergillus conidia and may, in a severely immunocompromised patient, disseminate to other ison with that caused by the other species of Aspergillus. Overall, 13 cases of invasive aspergillosis caused by A. terreus were organs [2, 6 -9] . Primary infection of nonpulmonary sites, most commonly affecting the skin or the paranasal sinuses, has been recognized: 11 primary pulmonary infections and 2 cases of primary peritonitis. The 11 cases of invasive pulmonary disease described [10 -12] .
Aspergillus fumigatus and Aspergillus flavus are the species were further evaluated in detail and the results were compared with those in other published studies from the past 12 years. most commonly causing invasive mold infections [2 -6, 13 -15] . The difference in incidence is related to environmental factors that support growth of a particular species [7, 8, 16 , Methods 17]. Other species of Aspergillus, such as A. niger and A. terreus, have also been identified as rare causes of invasive
Cases from the literature. The English-language literature disease [5, 6, 13, 14] .
was searched with use of the MEDLINE databases of the NaAlthough numerous individual cases of invasive disease tional Laboratory of Medicine. Publications describing IPA caused by A. terreus have been described in the past 12 years, caused by A. terreus, with or without dissemination, were idenno review describing multiple cases at one institution over an tified. Infected patients were analyzed by age, sex, underlying extended period of time has been published [18 -37] . These disease, primary disease treatment, transplant type (if applicareports include a number of isolated cases of localized nonpulble), site of presenting infection, presence of neutropenia, and monary infections, such as endophthalmitis, bursitis, endocardiorgan systems showing histologic evidence of infection. tis, and lymphadenitis [19, 21, 24, 27, 31, 35] and received therapeutic doses of amphotericin B (ú1,500 mg), Other 9 and two were treated with itraconazole. One patient at our This study was conducted to identify published cases of IPA caused by A. terreus and to compare these with cases occurring at our institution. A retrospective analysis of patients with inva-9.1% for that due to A. terreus, and 14.0% for that due to A. fumigatus. For 45.9% -60% of patients who died, the first sive aspergillosis diagnosed at the University of Nebraska Medical Center revealed that A. terreus was responsible for 13 of identification of aspergillosis was made at postmortem examination.
133 cases of invasive aspergillosis (9.8%); 11 primarily involved the pulmonary system and 2 involved the peritoneal A comparison of diseases caused by A. terreus was made through tabulation of data from 19 cases in the literature and cavity (table 1) . This frequency of A. terreus in our series is comparable with that reported in retrospective studies by five additional recent cases at our institution (table 3) . Ten patients were female, 13 were male, and the sex of one was Walmsley et al., where 3 of 24 isolates (12.5%) were A. terreus; by Wald et al., where 9 of 133 isolates (6.8%) from bone not reported. The median age was 41 years (range, 1 -80 years). The most common underlying disease was leukemia, in 10 marrow transplantation patients were A. terreus; and by Khoo and Denning, where 3 of 87 isolates (3.4%) causing invasive patients, all of whom received high-dose chemotherapy and five of whom underwent allogeneic bone marrow transplantaaspergillosis in patients with AIDS were A. terreus [4, 6, 15] . The overall rate of primary pulmonary infections (due to any tion. The next most common underlying condition was liver disease (three patients, all of whom underwent liver transAspergillus species) in our study was 72.9% (97 of 133 cases), and primary cutaneous infection was the second most common plantation). Overall, 13 of the 21 patients for whom information was recorded became neutropenic during the hospitalization source (12 cases). Eight of the 11 patients at our institution with IPA caused when aspergillosis occurred.
Eleven patients overall had invasive disease localized to the by A. terreus had hematologic malignancies: 6 had leukemia, and 2 had lymphoma (table 2). All of these patients underwent lungs only; the original diagnosis for these patients most frequently was made following a lung biopsy (eight cases) (table  aggressive chemotherapy and became neutropenic at some time  during hospitalization (table 3) . This association of A. terreus 3). All three cases diagnosed by culture of a bronchial washing specimen were subsequently confirmed by histologic examinainfection with leukemia had been shown by other investigators; Chang and King [18] , as well as Moore et al. [28] , each detion of lung tissue. Thirteen patients had primary IPA, which ultimately disseminated to extrapulmonary sites. All patients scribed patients with leukemia who received chemotherapy but did not undergo bone marrow transplantation [18, 28] . Goldwhose disseminated disease originated from a nonpulmonary site (patients 17, 22, and 23) or multiple sites detected in postberg et al. described a case of invasive disease caused by / 9c4c$$my38 04-10-98 01:03:45 cida UC: CID Heart, kidney, Flu Death spleen, lung NOTE. AA Å aplastic anemia; AG Å agranulocytosis of unknown origin; ALL Å acute lymphoblastic leukemia; AmB Å amphotericin B; AML Å acute myelogenous leukemia; AS Å acute stenosis; BM Å bone marrow; BM-R Å bone marrow, related; BM-U Å bone marrow, unrelated; CHB Å chronic hepatitis B; CLL Å chronic lymphoblastic leukemia; CML Å chronic myelogenous leukemia; 5-FC Å flucytosine; Flu Å fluconazole; GI Å gastrointestinal; HCV Å hepatitis C virus infection; IT Å idiopathic thrombocytopenia; Itr Å itraconazole; Ket Å ketoconazole; MD Å myelodysplasia; Mic Å miconazole; NHL Å nonHodgkin's lymphoma; NR Å not reported; PR Å present report; PSC Å peripheral stem cell; SBS Å small-bowel syndrome; TCD Å T cell deficiency.
* This patient received high-dose chemotherapy treatment. † This patient was included in the database for patients with invasive mold infections hospitalized at the University of Nebraska Medical Center. ‡ This patient underwent pulmonary lobectomy. § Aspergillosis diagnosed following postmortem examination.
x Patient admitted for brain abscess 247 days after allogeneic bone marrow transplant.
/ 9c4c$$my38 04-10-98 01:03:45 cida UC: CID CID 1998;26 (May)
A. terreus in a patient with acute lymphoblastic leukemia who caused by A. flavus was 7.3%, followed by 9.1% for A. terreus IPA and 14.0% for A. fumigatus IPA, with a combined survival underwent allogeneic bone marrow transplantation [22] . In four of our six patients with leukemia, allogeneic bone marrow of 10.5%. The ineffectiveness of amphotericin B in the treatment of aspergillosis has been shown numerous times and is transplantations were performed. Opportunistic fungal infections are more common under these circumstances because of again reflected in this study [2, 40] . Of the patients in this collected review, only three survived with IPA, and all had the high level of immunosuppression [1, 2, 5, 6] .
Two patients at our institution with non-Hodgkin's localized pulmonary infection. lymphoma developed IPA; both (patients 9 and 19) underwent
The surviving patient at our institution (patient 8) was not autologous stem cell rescues following treatment with highneutropenic and received therapy with both amphotericin B dose chemotherapy (table 3) . A number of similarities in the and itraconazole. In addition, aggressive surgical intervention clinical courses of these two lymphoma patients were noted, was utilized for this patient, including lobectomy of the infected including the initiation of amphotericin B therapy following lung. Robinson et al. have suggested that pulmonary resection detection of chest radiographic abnormalities 16 -17 days postbe performed for IPA in immunocompromised patients to inadmission; the diagnosis of IPA was confirmed 41 and 53 days crease chances of survival [33] . Patient 1, another survivor, postadmission, respectively. It is interesting that one patient was neutropenic and received amphotericin B. The remaining (number 19) developed disseminated aspergillosis despite resurvivor (patient 7) received both amphotericin B and itraconaceiving 2,430 mg of amphotericin B, whereas the second pazole. Itraconazole has shown some effectiveness in the treattient (number 9) had disease that remained localized to the ment of aspergillosis, but the response rates are considered no lung and received 1,276 mg of amphotericin B but died.
better than those reported for amphotericin B [41] . In in vitro The three remaining patients with A. terreus infection at our studies, A. terreus was markedly more susceptible to itraconainstitution had liver disease as an underlying condition (patients zole than to amphotericin B, suggesting that this antifungal 8, 11, and 24). Fungal infections are a common complication should be considered when A. terreus is causing invasive infecfollowing liver transplantation, with a reported incidence rangtion [42] . ing from 7% to 42% [38] . Even though a majority of fungal Extrapulmonary spread of A. terreus was noted in six of our infections in these patients are caused by Candida species, patients; dissemination to the heart was most common (four Ç20% are due to Aspergillus, with A. fumigatus and A. flavus patients) (table 3) . In a previous study at our institution of causing a majority of these infections. No detailed studies deinfection caused by all species of Aspergillus, the brain was scribing A. terreus as a cause of invasive aspergillosis in liver recognized as the most common site of dissemination [3] . In transplant patients have been reported. Likewise, A. terreus as four of the seven cases reported in the literature of disseminated a cause of infection in lung and heart/lung transplant recipients aspergillosis caused by A. terreus, dissemination to the heart has also not been reported, suggesting that patients undergoing was also recognized [23, 24, 35] . solid-organ transplantation are at low risk for infection caused Improved methods for the timely isolation and identification by A. terreus [39] . Two patients in our study (patients 8 and of the causative agent of aspergillosis are clearly needed. The 11) had aspergillosis confined to the lungs, while patient 24 ability to distinguish A. terreus from other species may be had disseminated disease involving multiple organs (table 3) .
important from an epidemiological standpoint, and as this study For both patient 11 and patient 24, the diagnosis was made suggests, it may also be important from both therapeutic and following portmortem examination.
prognostic standpoints [8, 43] . Even though amphotericin B is Neutropenia is considered a major risk factor for the developconsidered the antifungal of choice for treatment of IPA, treatment of invasive aspergillosis [2, 6, 17] . This was especially ment with this antifungal is still associated with an extremely evident in patients at our institution, where 63.6% (seven) of high mortality [3, 6, 40 ]. 11 patients with neutropenia developed A. terreus infections Our report suggests that surgical intervention, as well as during hospitalization, with a median neutropenia duration of combined therapy with amphotericin B and itraconazole for 27 days (range, 6 -42 days) (table 2). In comparison, A. fumigapatients with IPA caused by A. terreus, may be a treatment tus was isolated from 16 of 43 neutropenic patients developing option to consider. Additional studies are needed to evaluate IPA. This difference in percentage of A. terreus and A. fumigawhether newly available preparations of amphotericin B comtus infections among neutropenic patients was not statistically bined with itraconazole offer a therapeutic advantage over exsignificant (P Å .125). The lack of significance is due in part isting treatments for A. terreus infection [44] . to the small number of A. terreus infections analyzed, but the results suggest A. terreus may require a higher degree of immunosuppression before infection can occur.
Even though it is well known that the mortality associated
